Edwards Lifesciences EW Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's investing cash flow?
- Edwards Lifesciences (EW) reported investing cash flow of -$92.8M in Q1 2026.
- How has Edwards Lifesciences's investing cash flow changed year-over-year?
- Edwards Lifesciences's investing cash flow decreased by 208.8% year-over-year, from $85.3M to -$92.8M.
- What is the long-term trend for Edwards Lifesciences's investing cash flow?
- Over 2 years (2021 to 2025), Edwards Lifesciences's investing cash flow has grown at a -35.7% compound annual growth rate (CAGR), from -$1.72B to -$712.9M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.